INVITRO BINDING OF LORAZEPAM AND LORAZEPAM GLUCURONIDE TO CHOLESTYRAMINE, COLESTIPOL, AND ACTIVATED-CHARCOAL

被引：7

作者：

HERMAN, RJ ^{[1
]}

CHAUDHARY, A ^{[1
]}

机构：

[1] UNIV SASKATCHEWAN,DEPT PHARMACOL,SASKATOON S7N 0W0,SASKATCHEWAN,CANADA

来源：

PHARMACEUTICAL RESEARCH | 1991年 / 8卷 / 04期

关键词：

LORAZEPAM GLUCURONIDE; BINDING TO CHOLESTYRAMINE; COLESTIPOL; AND ACTIVATED CHARCOAL; ENTEROHEPATIC RECIRCULATION;

D O I：

10.1023/A:1015823816776

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

引用

页码：538 / 540

页数：3

共 18 条

[1]

ARABI Y, 1977, GUT, V18, pA969

[2] STUDIES OF INTESTINAL DIGESTION AND ABSORPTION IN THE HUMAN [J].

BORGSTROM, B ;

DAHLQVIST, A ;

LUNDH, G ;

SJOVALL, J .

JOURNAL OF CLINICAL INVESTIGATION, 1957, 36 (10) :1521-1536

[3] USE OF CHOLESTYRAMINE RESIN IN THE TREATMENT OF DIGITOXIN TOXICITY [J].

CADY, WJ ;

REHDER, TL ;

CAMPBELL, J .

AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1979, 36 (01) :92-94

[4]

CALDWELL JH, 1971, J CLIN INVEST, V550, P2638

[5]

GALLO DG, 1965, P SOC EXP BIOL MED, V120, P60

[6]

GREENBLATT DJ, 1988, J PHARMACOL EXP THER, V244, P674

[7] PHARMACOKINETICS AND BIOAVAILABILITY OF INTRAVENOUS, INTRAMUSCULAR, AND ORAL LORAZEPAM IN HUMANS [J].

GREENBLATT, DJ ;

SHADER, RI ;

FRANKE, K ;

MACLAUGHLIN, DS ;

HARMATZ, JS ;

ALLEN, MD ;

WERNER, A ;

WOO, E .

JOURNAL OF PHARMACEUTICAL SCIENCES, 1979, 68 (01) :57-63

[8]

GUENTERT TW, 1986, J PHARMACOL EXP THER, V238, P295

[9] DISPOSITION OF LORAZEPAM IN HUMAN-BEINGS - ENTEROHEPATIC RECIRCULATION AND 1ST-PASS EFFECT [J].

HERMAN, RJ ;

VANPHAM, JD ;

SZAKACS, CBN .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1989, 46 (01) :18-25

[10] ENHANCEMENT OF XENOBIOTIC ELIMINATION - ROLE OF INTESTINAL EXCRETION [J].

ISRAILI, ZH ;

DAYTON, PG .

DRUG METABOLISM REVIEWS, 1984, 15 (5-6) :1123-1159

← 1 2 →